Lerdelimumab Antibody
Lerdelimumab (CAT-152) is a human IgG4 monoclonal antibody designed to neutralize TGF-β2. It has been investigated preclinically as a potential anti-fibrotic agent to improve surgical outcomes in glaucoma, with studies conducted in both in vitro cell models and in vivo animal studies of wound healing.
Product Specifications
Target
TGF-beta/Smad
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Stem Cell & Developmental Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
